TMCnet News
Global Cognitive Assessment and Training (Pen and Paper-based, Hosted, Biometrics) Market 2017-2021DUBLIN, August 14, 2017 /PRNewswire/ -- The "Cognitive Assessment and Training Market - Global Forecast to 2021" report has been added to Research and Markets' offering. The cognitive assessment and training market size is expected to grow from USD 1.98 billion in 2016 to USD 8.06 billion by 2021, at a Compound Annual Growth Rate (CAGR) of 32.3% during the forecast period The growing number of aged people across the globe is one of the factors driving the incidents of cognitive impairments. With the increase in the number of baby boomers in developing countries crossing the age of 65 years, the incidence of cognitive impairments is expected to increase dramatically. Moreover, it has become very crucial to introduce new approaches to prevent and tackle the primary, secondary, and tertiary cognitive impairments. People are becoming more concerned regarding their memory performance and enhancement. Today, almost all the assessment and training methods involve at least one measure, which is monitored, scored, or interpreted with the help of computers or other technologies. However, stringent government regulations across the globe, negative publicity about brain training efficiency, and time constraints in developing clinically validated brain fitness software have hindered the growth of the cognitive assessment and training market. The pen- and paper-based assessment type is a traditional approach for measuring the cognitive behavior of an individual and remains largely the standard for the assessment of cognitive decline. The segment includes revenues generated by performing and analyzing pen- and paper-based cognitive assessment tests, such as Standardized Mini-Mental Status Examination (SMMSE), Alzheimer's Disease Assessment Scale-Cognitive (ADAS-Cog), and clock drawing test by doctors and other professionals. Clinical trials are mainly used to identify, measure, or monitor cognitive impairments and cognitive changes; such assessments are performed across multiple languages and cultural groups in diffrent clinical and social settings. The use of clinical trial involves the procedure to develop drug for cognitively impaired patient. It is a long procedure that requires high amount of funding from pharmaceutical vendors and other organization. Hence, the need to develop drugs and requirement of clinical testing of patient would boost the growth for clinical trials. In the process of determining and verifying the market size for several segments and subsegments gathered through secondary research, extensive primary interviews were conducted with key people. Market Dynamics Drivers
Restraints
Opportunities
Challenges
Key Topics Covered: 1 Introduction
Media Contact: Laura Wood, Senior Manager
|